Marshall Wace
AMGN icon

Marshall Wace’s Amgen AMGN Stock Holding History

Marshall Wace’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Buy
+300
New +$107K ﹤0.01% 2891
2024
Q3 		– Sell
-96,200
Closed -$30.1M – 2459
2024
Q2 		$30.1M Buy
+96,200
New +$28.3M 0.04% 383
2023
Q2 		– Sell
-19,400
Closed -$4.69M – 2428
2023
Q1 		$4.69M Buy
+19,400
New +$4.76M 0.01% 1034

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Marshall Wace's AMGN Position: Q1 2026 in Review

Marshall Wace increased its Amgen (AMGN) stake by 221% in Q1 2026, buying an estimated $77.7M and bringing the position to 316,917 shares worth $112M. The position accounts for 0.11% of the portfolio, ranked #150.

Marshall Wace first reported a position in AMGN in Q2 2013 and has held it in 37 quarters since. The position peaked at $416M in Q3 2023. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Marshall Wace held 316,917 shares of Amgen worth $112M as of Q1 2026.
  • Marshall Wace bought 218,065 Amgen shares in Q1 2026, an estimated $77.7M.
  • Amgen made up 0.11% of Marshall Wace's portfolio in Q1 2026, its #150 holding.
  • Marshall Wace first reported a position in Amgen in Q2 2013 and has held it in 37 quarters since.
  • Marshall Wace's Amgen position peaked at $416M in Q3 2023.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.